ID   PGCB_RAT                Reviewed;         883 AA.
AC   P55068; Q62860; Q63040; Q63513;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   03-AUG-2022, entry version 175.
DE   RecName: Full=Brevican core protein;
DE   AltName: Full=Brain-enriched hyaluronan-binding protein;
DE            Short=BEHAB;
DE   Flags: Precursor;
GN   Name=Bcan; Synonyms=Behab;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND GPI-ANCHOR AT SER-622 (ISOFORM 2).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7592978; DOI=10.1074/jbc.270.45.27206;
RA   Seidenbecher C.I., Richter K., Rauch U., Faessler R., Garner C.C.,
RA   Gundelfinger E.D.;
RT   "Brevican, a chondroitin sulfate proteoglycan of rat brain, occurs as
RT   secreted and cell surface glycosylphosphatidylinositol-anchored isoforms.";
RL   J. Biol. Chem. 270:27206-27212(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 396-407.
RC   TISSUE=Brain;
RX   PubMed=7488217; DOI=10.1006/bbrc.1995.2713;
RA   Yamada H., Watanabe K., Shimonaka M., Yamasaki M., Yamaguchi Y.;
RT   "cDNA cloning and the identification of an aggrecanase-like cleavage site
RT   in rat brevican.";
RL   Biochem. Biophys. Res. Commun. 216:957-963(1995).
RN   [3]
RP   INTERACTION WITH TNR.
RX   PubMed=9294172; DOI=10.1073/pnas.94.19.10116;
RA   Aspberg A., Miura R., Bourdoulous S., Shimonaka M., Heinegard D.,
RA   Schachner M., Ruoslahti E., Yamaguchi Y.;
RT   "The C-type lectin domains of lecticans, a family of aggregating
RT   chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein
RT   interactions independent of carbohydrate moiety.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:10116-10121(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-423.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7512973; DOI=10.1083/jcb.125.2.495;
RA   Jaworski D.M., Kelly G.M., Hockfield S.;
RT   "BEHAB, a new member of the proteoglycan tandem repeat family of
RT   hyaluronan-binding proteins that is restricted to the brain.";
RL   J. Cell Biol. 125:495-509(1994).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-413, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: May play a role in the terminally differentiating and the
CC       adult nervous system during postnatal development. Could stabilize
CC       interactions between hyaluronan (HA) and brain proteoglycans. Isoform 2
CC       may function as a chondroitin sulfate-bearing cell surface receptor.
CC   -!- SUBUNIT: Interacts with TNR. {ECO:0000269|PubMed:9294172}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Secreted, extracellular space,
CC       extracellular matrix.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Membrane; Lipid-anchor, GPI-anchor.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P55068-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P55068-2; Sequence=VSP_003076, VSP_003077;
CC   -!- TISSUE SPECIFICITY: Brain.
CC   -!- DEVELOPMENTAL STAGE: Isoform 1 increases from day P4 to P64. Isoform 2
CC       increases after day P8.
CC   -!- PTM: Contains mostly chondroitin sulfate.
CC   -!- SIMILARITY: Belongs to the aggrecan/versican proteoglycan family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA82215.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X79881; CAA56255.1; -; mRNA.
DR   EMBL; X86406; CAA60160.1; -; mRNA.
DR   EMBL; U37142; AAA87847.1; -; mRNA.
DR   EMBL; Z28366; CAA82215.1; ALT_FRAME; mRNA.
DR   PIR; A53908; A53908.
DR   PIR; S49126; S49126.
DR   RefSeq; NP_001028837.1; NM_001033665.1.
DR   RefSeq; NP_037048.2; NM_012916.2.
DR   AlphaFoldDB; P55068; -.
DR   SMR; P55068; -.
DR   BioGRID; 247431; 2.
DR   IntAct; P55068; 1.
DR   MINT; P55068; -.
DR   STRING; 10116.ENSRNOP00000025496; -.
DR   GlyGen; P55068; 2 sites.
DR   iPTMnet; P55068; -.
DR   PhosphoSitePlus; P55068; -.
DR   SwissPalm; P55068; -.
DR   PaxDb; P55068; -.
DR   PRIDE; P55068; -.
DR   ABCD; P55068; 2 sequenced antibodies.
DR   GeneID; 25393; -.
DR   KEGG; rno:25393; -.
DR   UCSC; RGD:2194; rat. [P55068-1]
DR   CTD; 63827; -.
DR   RGD; 2194; Bcan.
DR   eggNOG; KOG4297; Eukaryota.
DR   InParanoid; P55068; -.
DR   PhylomeDB; P55068; -.
DR   Reactome; R-RNO-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-RNO-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   Reactome; R-RNO-2022870; Chondroitin sulfate biosynthesis.
DR   Reactome; R-RNO-2022923; Dermatan sulfate biosynthesis.
DR   Reactome; R-RNO-2024101; CS/DS degradation.
DR   Reactome; R-RNO-3000178; ECM proteoglycans.
DR   PRO; PR:P55068; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0031225; C:anchored component of membrane; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043194; C:axon initial segment; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0031012; C:extracellular matrix; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0033268; C:node of Ranvier; IDA:RGD.
DR   GO; GO:0072534; C:perineuronal net; IDA:RGD.
DR   GO; GO:0098966; C:perisynaptic extracellular matrix; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; IDA:RGD.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:UniProtKB-KW.
DR   GO; GO:0007420; P:brain development; IEP:RGD.
DR   GO; GO:0007160; P:cell-matrix adhesion; IDA:RGD.
DR   GO; GO:0007417; P:central nervous system development; IBA:GO_Central.
DR   GO; GO:0042063; P:gliogenesis; IEP:RGD.
DR   GO; GO:0021766; P:hippocampus development; ISO:RGD.
DR   GO; GO:1990138; P:neuron projection extension; IDA:RGD.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; IEP:RGD.
DR   GO; GO:0001501; P:skeletal system development; IBA:GO_Central.
DR   GO; GO:0060074; P:synapse maturation; ISO:RGD.
DR   CDD; cd00033; CCP; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.10.100.10; -; 3.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   InterPro; IPR000538; Link_dom.
DR   InterPro; IPR035976; Sushi/SCR/CCP_sf.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   Pfam; PF00008; EGF; 1.
DR   Pfam; PF00059; Lectin_C; 1.
DR   Pfam; PF00084; Sushi; 1.
DR   Pfam; PF07686; V-set; 1.
DR   Pfam; PF00193; Xlink; 2.
DR   PRINTS; PR01265; LINKMODULE.
DR   SMART; SM00032; CCP; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00406; IGv; 1.
DR   SMART; SM00445; LINK; 2.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF56436; SSF56436; 3.
DR   SUPFAM; SSF57535; SSF57535; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
DR   PROSITE; PS01241; LINK_1; 2.
DR   PROSITE; PS50963; LINK_2; 2.
DR   PROSITE; PS50923; SUSHI; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Direct protein sequencing; Disulfide bond;
KW   EGF-like domain; Extracellular matrix; Glycoprotein; GPI-anchor;
KW   Hyaluronic acid; Immunoglobulin domain; Lectin; Lipoprotein; Membrane;
KW   Phosphoprotein; Proteoglycan; Reference proteome; Repeat; Secreted; Signal;
KW   Sushi.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..883
FT                   /note="Brevican core protein"
FT                   /id="PRO_0000017513"
FT   DOMAIN          35..154
FT                   /note="Ig-like V-type"
FT   DOMAIN          156..251
FT                   /note="Link 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00323"
FT   DOMAIN          256..353
FT                   /note="Link 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00323"
FT   DOMAIN          622..658
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          658..786
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          789..849
FT                   /note="Sushi"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   REGION          389..574
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          859..883
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        452..469
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        471..501
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        129
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        336
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        56..136
FT                   /evidence="ECO:0000250"
FT   DISULFID        178..249
FT                   /evidence="ECO:0000250"
FT   DISULFID        202..223
FT                   /evidence="ECO:0000250"
FT   DISULFID        276..351
FT                   /evidence="ECO:0000250"
FT   DISULFID        300..321
FT                   /evidence="ECO:0000250"
FT   DISULFID        626..637
FT                   /evidence="ECO:0000250"
FT   DISULFID        631..646
FT                   /evidence="ECO:0000250"
FT   DISULFID        648..657
FT                   /evidence="ECO:0000250"
FT   DISULFID        692..784
FT                   /evidence="ECO:0000250"
FT   DISULFID        760..776
FT                   /evidence="ECO:0000250"
FT   DISULFID        791..834
FT                   /evidence="ECO:0000250"
FT   DISULFID        820..847
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         625..645
FT                   /note="DCIPSPCHNGGTCLEEKEGFR -> NSAEGSMPAFLLFLLLQLWDT (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_003076"
FT   VAR_SEQ         646..883
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_003077"
FT   CONFLICT        51..52
FT                   /note="AL -> WV (in Ref. 4; CAA82215)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        503
FT                   /note="V -> L (in Ref. 2; AAA87847)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        518..519
FT                   /note="TV -> PA (in Ref. 2; AAA87847)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        526
FT                   /note="G -> R (in Ref. 2; AAA87847)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        541
FT                   /note="G -> A (in Ref. 2; AAA87847)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        556
FT                   /note="R -> S (in Ref. 2; AAA87847)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        573
FT                   /note="E -> A (in Ref. 2; AAA87847)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        583
FT                   /note="V -> L (in Ref. 2; AAA87847)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        649
FT                   /note="V -> L (in Ref. 2; AAA87847)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        670
FT                   /note="P -> A (in Ref. 2; AAA87847)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        738
FT                   /note="P -> A (in Ref. 2; AAA87847)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        809
FT                   /note="R -> A (in Ref. 2; AAA87847)"
FT                   /evidence="ECO:0000305"
FT   LIPID           P55068-2:622
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000305|PubMed:7592978"
SQ   SEQUENCE   883 AA;  96057 MW;  AC7ACC40CB53ED37 CRC64;
     MIPLLLSLLA ALVLTQAPAA LADDLKEDSS EDRAFRVRIG AAQLRGVLGG ALAIPCHVHH
     LRPPPSRRAA PGFPRVKWTF LSGDREVEVL VARGLRVKVN EAYRFRVALP AYPASLTDVS
     LVLSELRPND SGVYRCEVQH GIDDSSDAVE VKVKGVVFLY REGSARYAFS FAGAQEACAR
     IGARIATPEQ LYAAYLGGYE QCDAGWLSDQ TVRYPIQNPR EACYGDMDGY PGVRNYGVVG
     PDDLYDVYCY AEDLNGELFL GAPPGKLTWE EARDYCLERG AQIASTGQLY AAWNGGLDRC
     SPGWLADGSV RYPIITPSQR CGGGLPGVKT LFLFPNQTGF PSKQNRFNVY CFRDSAHPSA
     FSEASSPASD GLEAIVTVTE KLEELQLPQE AVESESRGAI YSIPITEDGG GGSSTPEDPA
     EAPRTPLESE TQSVAPPTGS SEEEGEALEE EERFKDTETP KEEKEQENLW VWPTELSSPL
     PTGLETEHSL SQVSPPAQAV LQVGASPSPR PPRVHGPTVE TLQPPGEGSL TSTPDGAREV
     GGETGSPELS GVPREREEAG SSSLEDGPSL LPETWAPVGT REVETPSEEK SGRTVLTGTS
     VQAQPVLPTD SASRGGVAVA PSSGDCIPSP CHNGGTCLEE KEGFRCLCVP GYGGDLCDVG
     LHFCSPGWEP FQGACYKHFS TRRSWEEAES QCRALGAHLT SICTPEEQDF VNDRYREYQW
     IGLNDRTIEG DFLWSDGPPL LYENWNPGQP DSYFLSGENC VVMVWHDQGQ WSDVPCNYHL
     SYTCKMGLVS CGPPPQLPLA QIFGRPRLRY AVDTVLRYRC RDGLAQRNLP LIRCQENGLW
     EAPQISCVPR RPARALRSMT APEGPRGQLP RQRKALLTPP SSL
//
